Evidence map›Paper›PMID 31795491›Full record

ReviewGenes2019

The Molecular Genetics of Gordon Syndrome.

Holly Mabillard, John A Sayer

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. A case report on pseudohypoaldosteronism with a pathogenic mutation ofJournal of family medicine and primary care · 2025
    Article
  10. Article
  11. Article
  12. Pseudohypoaldosteronism type II: The Relevance of A Challenging Diagnosis.European journal of case reports in internal medicine · 2025
    Article
  13. Review
  14. Review
  15. Article
  16. Genetics of Hypertension: From Monogenic Analysis to GETomics.Journal of cardiovascular development and disease · 2024
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Holly MabillardRenal Services, The Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.
John A SayerRenal Services, The Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK.
Newcastle upon Tyne Hospitals NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gordon syndrome is a rare inherited monogenic form of hypertension, which is associated with hyperkalaemia and metabolic acidosis. Since the recognition of this predominantly autosomal dominant condition in the 1960s, the study of families with Gordon syndrome has revealed four genes

Indexed as

Genetic Predisposition to DiseaseAdaptor Proteins, Signal TransducingArthrogryposisCleft PalateClubfootCullin ProteinsHand Deformities, CongenitalHumansMicrofilament ProteinsMutationProtein BindingProtein Serine-Threonine KinasesWNK Lysine-Deficient Protein Kinase 1Adaptor Proteins, Signal TransducingCUL3 protein, humanCullin ProteinsKLHL3 protein, humanMicrofilament ProteinsProtein Serine-Threonine KinasesWNK1 protein, humanWNK4 protein, humanWNK Lysine-Deficient Protein Kinase 1CUL3geneticsGordon syndromeKLHL3tubulopathyWNK1WNK4

Identifiers

PMID31795491
PMCPMC6947027
OpenAlexW2990618077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.